The community site for and by
developmental and stem cell biologists

DanStem is taking stem cell research to the next phase

Posted by , on 24 August 2017

With a new grant of almost 15 million EUR from the Novo Nordisk Foundation, DanStem scientists will be focused on a new programme for translational hematology.

The Programme could have a major impact on treatment of haematological malignancies. The primary aim is to identify novel treatments for patients with blood cancers AML (Acute Myeloid Leukaemia) and MDS (Myelodysplastic Syndrome) for which treatments and success rates have changed little in the last decades.

Professor Kristian Helin will head the Programme, which will include collaboration with researchers from Rigshospitalet, Denmark’s largest hospital. Major activities include:

  • Identifying and characterizing cancer stem cells from patients with blood cancer;
  • Identifying the best available treatment for individual patients by screening patient-derived cancer stem cells for sensitivity toward a panel of approved drugs (personalized medicine); and
  • Collaborating with companies to develop new drugs for treating blood cancer.

See more information here.

Thumbs up (No Ratings Yet)
Loading...

Categories: Funding, News

Leave a Reply

Your email address will not be published. Required fields are marked *

Get involved

Create an account or log in to post your story on the Node.

Sign up for emails

Subscribe to our mailing lists.

Most-read posts in May

Do you have any news to share?

Our ‘Developing news’ posts celebrate the various achievements of the people in the developmental and stem cell biology community. Let us know if you would like to share some news.